Kathleen Hallisey Rubins Grants Power of Attorney for SEC Filings to FibroBiologics Executives

This Form 3 filing discloses that Kathleen Hallisey Rubins, a director of FibroBiologics, Inc., has granted a limited power of attorney to three company executives: Ruben A. Garcia (General Counsel), Jason D. Davis (CFO), and Pete O'Heeron (CEO). The power of attorney authorizes these executives to prepare, sign, and file various SEC forms on Rubins' behalf, including Forms 3, 4, 5, and Schedule 13D/G, as well as manage EDGAR access. The filing also reports that Rubins holds 562 stock options with an exercise price of $65.60 per share, which vest over three years and become fully exercisable on September 26, 2025, with an expiration date of September 26, 2032. The power of attorney remains in effect until Rubins is no longer required to file forms related to FibroBiologics securities.